News
Merck (NYSE:MRK) announced Wednesday that the U.S. Food and Drug Administration (FDA) granted priority review for its request ...
Rahway: Merck, known as MSD outside of the United States and Canada, has announced that the U.S. Food and Drug Administration ...
Merck’s bid to update Winrevair’s label advances with FDA priority review, backed by Phase III ZENITH data showing a 76% ...
The Lakers pivoted to Jake LaRavia after losing Dorian Finney-Smith, earning praise from rival execs as a savvy NBA Free ...
Priority Cycles' Current Plus e-commuter bike delivers good range and power, plus features a low-maintenance Gates belt-drive ...
The FDA approval of Vimkunya has given the chikungunya vaccine’s owner, Bavarian Nordic, an extra financial windfall. | The ...
The upgraded Priority Current Plus goes fast and goes far with little effort, especially thanks to the new throttle. It’s a competent commuter and a good-looking bike with quality componentry and ...
The FDA announced a new national priority voucher plan that aims to cut drug review times, while Headspace launches direct-to ...
The FDA is launching a program to reward companies with accelerated drug review and speedy agency feedback, if their actions ...
While there's little disagreement that speeding drug approvals would be a good thing, there are more questions than answers ...
Rare disease priority review vouchers do not expire, but the program does and it must be renewed by Congress. Lawmakers failed to do so at the end of 2024. PRVs have also become commodities that ...
The FDA is introducing a new priority voucher program designed to shorten the drug review process from 10 to 12 months down to one or two months, according to the agency. The federal outfit’s ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results